OVERVIEW

Breast Cancer Clinical Case Series: The Year in Review is organized by Penn Medicine - Continuing Medical and Interprofessional Education and will be held on Jun 28, 2018 at Sheraton Valley Forge Hotel, King of Prussia, Pennsylvania, United States of America.

The target audience for this medical event is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of breast cancer may also participate. This CME Conference has been approved for a maximum of 1.75 AMA PRA Category 1 Credits.

Conference Description :
The purpose of this educational activity is to bring together breast cancer specialists to highlight the state-of-the-art in multidisciplinary patient care. This activity will feature clinical updates in diagnosis and local, regional, and systemic therapies. Additionally, this activity will review promising clinical trials and clinical controversies in breast cancer management.

Conference Objectives are :
• Discuss clinical trial evidence that allows for the personalization of care in the management of early and advanced forms of breast cancer.
• Assess current and evolving roles for prognostic and predictive biomarkers to stratify risk and inform clinical decision making in the management of breast cancer.
• Examine recent clinical trial results concerning the use of novel breast cancer treatment strategies.

Additional details will be posted as soon as they are available.

KEY DATES

Event Start Date
28 Jun, 2018
Event Start Date
Event End Date
28 Jun, 2018
Event End Date

SPECIALITIES

Oncology

SUGGESTED HOTELS

CONFERENCE VENUE

LocationSheraton Valley Forge Hotel
480 North Gulph Road

RELATED CONFERENCES & LIVE WEBINARS

Feb 01 - 02, 2027 | Dubai, Dubai, UAE

Oncology
30 CME
...
More actions
GB£19

Feb 01 - 02, 2027 | Dubai, Dubai, UAE

Pathology
30 CME
...
More actions
GB£45

Oct 29 - 30, 2026 | Orlando, Florida, USA

Oncology
More actions
US$235